Temperature-programmable and enzymatically solidifiable gelatin-based bioinks enable facile extrusion bioprinting.

Huimin He1,2, Duo Li1,2,3, Zifeng Lin1

  • 1Research Center for Human Tissue and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, People's Republic of China.

Biofabrication
|June 4, 2020
PubMed
Summary

Chemically modified gelatin bioinks with ureido-pyrimidinone (UPy) and tyramine (Tyr) offer enhanced printability and fidelity for tissue engineering. These bioinks support high cell viability and function in complex 3D constructs.

Related Concept Videos